Thursday, April 25, 2024
HomeCancerWays To Test For Prostate Cancer

Ways To Test For Prostate Cancer

Cancer May Spread From Where It Began To Other Parts Of The Body

How to Test for Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD

When cancer spreads to another part of the body, it is called metastasis. Cancer cells break away from where they began and travel through the lymph system or blood.

  • Lymph system. The cancer gets into the lymph system, travels through the lymph vessels, and forms a tumor in another part of the body.
  • Blood. The cancer gets into the blood, travels through the blood vessels, and forms a tumor in another part of the body.

The metastatic tumor is the same type of cancer as the primary tumor. For example, if prostate cancer spreads to the bone, the cancer cells in the bone are actually prostate cancer cells. The disease is metastatic prostate cancer, not bone cancer.

Denosumab, a monoclonal antibody, may be used to preventbone metastases.

After Prostate Cancer Has Been Diagnosed Tests Are Done To Find Out If Cancer Cells Have Spread Within The Prostate Or To Other Parts Of The Body

The process used to find out if cancer has spread within theprostate or to other parts of the body is called staging. The information gathered from the staging process determines the stage of the disease. It is important to know the stage in order to plan treatment. The results of the tests used to diagnoseprostate cancer are often also used to stage the disease. In prostate cancer, staging tests may not be done unless the patient has symptoms or signs that the cancer has spread, such as bone pain, a high PSA level, or a high Gleason score.

The following tests and procedures also may be used in the staging process:

Is Active Surveillance Right For You

There are some risks associated with active surveillance. They include a low risk of infection with every biopsy and a very low risk of cancer progressing in any one interval of surveillance. Sometimes men choose active surveillance for a period of time and then decide to undergo treatment.

Thousands of UCSF patients have chosen active surveillance to initially manage their prostate cancer. This is one of the largest groups of patients on active surveillance in the world. About one-third of these men receive treatment by five years and 50% by 10 years. The window of opportunity to cure prostate cancer is usually measurable in years or even decades. In fact, treatment results for these men appear to be similar to what would have been expected had they chosen treatment right after their original diagnosis. Based on our experience and those reported from other centers, the risk of significant cancer progression in the short to intermediate term, while not zero, appears to be very low.

Some men with risk factors such as family history, genetic mutations and being African American may still be candidates for active surveillance but need a more careful or intense surveillance regimen to make sure any early signs of progression are identified.

The most common reason for seeking treatment is a biopsy that shows the cancer is growing or becoming more aggressive in appearance . Changes in PSA or cancer stage based on imaging results may also lead to treatment.

Read Also: Prostate Cancer Statistics Worldwide 2020

A Biopsy Is Done To Diagnose Prostate Cancer And Find Out The Grade Of The Cancer

A transrectal biopsy is used to diagnose prostate cancer. A transrectal biopsy is the removal of tissue from the prostate by inserting a thin needle through the rectum and into the prostate. This procedure may be done using transrectal ultrasound or transrectal MRI to help guide where samples of tissue are taken from. A pathologist views the tissue under a microscope to look for cancer cells.

Sometimes a biopsy is done using a sample of tissue that was removed during a transurethral resection of the prostate to treat benign prostatic hyperplasia.

If cancer is found, the pathologist will give the cancer a grade. The grade of the cancer describes how abnormal the cancer cells look under a microscope and how quickly the cancer is likely to grow and spread. The grade of the cancer is called the Gleason score.

To give the cancer a grade, the pathologist checks the prostate tissue samples to see how much the tumor tissue is like the normal prostate tissue and to find the two main cell patterns. The primary pattern describes the most common tissue pattern, and the secondary pattern describes the next most common pattern. Each pattern is given a grade from 3 to 5, with grade 3 looking the most like normal prostate tissue and grade 5 looking the most abnormal. The two grades are then added to get a Gleason score.

What Should I Expect During A Prostate Exam

The Problem with PSA Screenings, Prostate Cancer and Risk

As mentioned above, there are two types of screenings that your healthcare provider may use to detect prostate cancer: a PSA blood test and a digital rectal exam . Research shows that the PSA blood test is more effective for detecting prostate cancer. However, the DRE can still find cancer in people with normal PSA levels. For this reason, many healthcare providers recommend both.

Neither test confirms you have prostate cancer, which is why theyre considered screening assessments rather than diagnostic tests.

PSA blood test

For this test, your healthcare provider simply draws a sample of your blood and sends it to a lab for analysis. The PSA blood test measures the amount of prostate-specific antigen in your blood.

There is no official cutoff score that can determine whether or not you have prostate cancer. Instead, the results are used as a gauge to determine if more testing is needed.

If you have a high PSA, you may need further testing such as a prostate biopsy, MRI or other lab tests to determine if prostate cancer may be present.

Digital rectal exam

During a DRE, your healthcare provider inserts a lubricated, gloved finger into your rectum. This way, they can feel your prostate to see if there are any lumps or bumps on the back portion of the gland .

Also Check: Life Expectancy Of Metastatic Prostate Cancer

Prognosis For Prostate Cancer

The prognosis is the likely outcome of a disease.

If the test results show prostate cancer, you may wish to speak with your treatment team about the prognosis.

The doctors will look at the stage and grade of the cancer as well as your age and general health to give a prognosis, but no doctor can predict the exact outcome for you.

Who Is At Risk For Prostate Cancer

Certain men are at higher risk than others for prostate cancer, which may affect when they should start being screened. The risk increases with age, particularly after age 50. Some risk factors include:

  • African American men are twice as likely as white men to develop the disease.
  • Having a family history a father or a brother diagnosed with prostate cancer, particularly if it is at a relatively early age increases the risk.
  • Having a family history of breast and ovarian cancer may also be associated with an inherited risk of developing prostate cancer
  • High-fat diet and/or obesity

Dont Miss: Prostate Cancer Metastasis To Spine

You May Like: Prostate Cancer Complementary And Alternative Medicine

What Causes Prostate Cancer

The exact cause of prostate cancer is not known. The tumor arises from cells with abnormal changes in the deoxyribonucleic acid of the prostate.

Certain factors can increase the risk of prostate cancer. They include

  • Age: The risk of prostate cancer increases with age. It is most commonly seen in people aged older than 50 years of age.
  • Ethnic groups: African Americans have a higher risk of prostate cancer than other ethnic groups. Cancer in this population is also more likely to be aggressive.
  • Family history: If a first-degree relative has prostate cancer, it increases the risk as well. Having the genes in the family that increase the risk of breast cancer or a strong family history of breast cancer also increases the risk of developing prostate cancer.
  • Obesity:Obese people have a higher risk of developing prostate cancer, which could also be aggressive and recurrent despite treatment.

Should I Poop Before A Prostate Exam

New Test to Detect Prostate Cancer Now Available

You dont need to change any bathroom habits prior to your appointment. If you feel like you need to poop before your exam, then its fine to do so. But dont worry if you just dont have the urge. The prostate exam shouldnt make you feel like you need to go.

Theres no need to be embarrassed about fecal matter during your prostate exam. Your healthcare provider is experienced in performing this exam and will do everything to ensure your comfort during the process.

Recommended Reading: Neoplasm Of Uncertain Behavior Of Prostate

Further Tests You Might Need

“Historically, we’ve jumped to a biopsy for patients,” Houman said. “However, we have a newer technology called a prostate MRI, which essentially looks into the prostate.”

He said prostate magnetic resonance imaging serves two purposes:

  • It identifies any lesions, including potentially cancerous lesions, in the prostate.
  • It can characterize each lesion and give a grade between 1 and 5, with 1 being highly unlikely it is cancerous and 5 being highly likely it is cancerous
  • As well as a prostate MRI, your doctor might conduct additional tests. Ramin said these might include:

    Private Prostate Cancer Testing

    Are you considering getting a private prostate cancer test? We can help.

    to learn about how we diagnose and treat prostate cancer at The Royal Marsden, Private Care at Cavendish Square.

    We offer consultant-led appointments, assessments and diagnostics all on the same day. Do you want to book a consultation at our one-stop urological cancer service? .

    Don’t Miss: Blood In Urine After Prostate Biopsy

    Options For Dealing With Recurrence

    With a persistently increasing PSA, the suspicion for recurrence increases. The most important factor in assessing your long-term outcome is determining the location of the prostate cancer cells producing the PSA. Advanced imaging techniques, such as MRI and PSMA PET/CT, are often helpful in learning where the cancer is located, and in the case of post-radiation recurrence, repeat biopsy may be required.

    If a man underwent surgery as an initial treatment, revisiting the post-operative pathology report may help to identify what contributed to the recurrence. If there was still cancer present , the cancer was aggressive , or genomic profiling of the tumor showed high-risk features, several options are available:

    • EBRT to the prostate bed with or without the pelvis.
    • EBRT accompanied by hormone therapy. The duration of hormone therapy will depend on the PSA level just prior to radiation and to a lesser extent on the Gleason score and staging of the cancer.
    • Systemic treatment using hormone therapy, other treatments for those at risk for metastatic disease, or a combination.
    • Active surveillance if the remaining cancer appears insignificant. You and your doctor can decide whether to intervene more aggressively and, if so, when.

    If you’re seeking additional or different approaches, you may be eligible to participate in an appropriate clinical trial . You can research this with the help of your doctor.

    There Is No Standard Or Routine Screening Test For Prostate Cancer

    When is PSA test done &  Screening for Prostate Cancer

    Although there are no standard or routine screening tests for prostate cancer, the following tests are being used or studied to screen for it:

    Digital rectal exam

    Digital rectal exam is an exam of the rectum. The doctor or nurse inserts a lubricated, gloved finger into the lower part of the rectum to feel the prostate for lumps or anything else that seems unusual.

    Prostate-specific antigen test

    A prostate-specific antigen test is a test that measures the level of PSA in the blood. PSA is a substance made mostly by the prostate that may be found in an increased amount in the blood of men who have prostate cancer. The level of PSA may also be high in men who have an infection or inflammation of the prostate or benign prostatic hyperplasia .

    A PSA test or a DRE may be able to detect prostate cancer at an early stage, but it is not clear whether early detection and treatment decrease the risk of dying from prostate cancer.

    Studies are being done to find ways to make PSA testing more accurate for early cancer detection.

    Read Also: How To Avoid Prostate Cancer

    What Tests Detect Prostate Cancer Early

    Because prostate cancer cant necessarily be detected at home, its a good idea to learn about the tests that provide early detection. Keep in mind that these tests cant decipher whether or not you have prostate cancer and, following the test, your doctor will most likely suggest a prostate biopsy. If youre wondering how to check for prostate cancer at home, your best bet is to leave it to your health care professional.

    Does It Matter Where Treatment Is Performed

    A large body of evidence shows that in the case of surgery for prostate cancer, surgical experience matters greatly. Medical centers and surgeons performing a high number of prostatectomies per year demonstrate better outcomes in terms of both cancer control and quality of life than those performing relatively low numbers. We don’t have similar data regarding radiation outcomes, but performing brachytherapy well certainly requires expertise and experience, particularly in prostate ultrasound. Planning and administering EBRT effectively has many subtleties, which likely translate to better outcomes with more experienced doctors. No matter what the practice volume of specific surgeons or radiation oncologists, they should be able to discuss their own demonstrated outcomes both in terms of cancer control and quality of life.

    Recommended Reading: What Is The Psa Test For Prostate

    What If My Test Results Are Abnormal

    If the results of the PSA test or the DRE suggest that you might have prostate cancer, your doctor will conduct further testing. The PSA test may be repeated, or you may be sent to a specialist for more tests such as a biopsy.

    Detecting prostate cancer early gives you the best chance of living longer. In fact, when it is caught early, the 5-year survival rate is over 99 percent.

    Learn

    What Are Some Of The Limitations And Potential Harms Of The Psa Test For Prostate Cancer Screening

    Avoid prostate biopsies with new cancer screening

    Detecting prostate cancer early may not reduce the chance of dying from prostate cancer. When used in screening, the PSA test can help detect small tumors. Having a small tumor found and treated may not, however, reduce the chance of dying from prostate cancer. That is because many tumors found through PSA testing grow so slowly that they are unlikely to be life threatening. Detecting such tumors is called overdiagnosis, and treating them is called overtreatment.

    Overtreatment exposes a person unnecessarily to the potential complications associated with prostate surgery and radiation therapy. These include urinary , gastrointestinal , and sexual side effects .

    In addition, finding cancer early may not help someone who has a fast-growing or aggressive prostate tumor that may have spread to other parts of the body before being detected.

    The PSA test may give false-positive results. A false-positive test result occurs when the PSA level is elevated but no cancer is actually present. A false-positive test result may create anxiety and lead to additional medical procedures, such as a prostate biopsy, that can be harmful. Possible side effects of biopsies include serious infections, pain, and bleeding.

    False-positive test results are common with PSA screening only about 25% of people who have a prostate biopsy due to an elevated PSA level are found to have prostate cancer when a biopsy is done .

    You May Like: Famous People With Prostate Cancer

    Should I Be Screened For Prostate Cancer

    Since there are benefits and risks to prostate screening, you should talk with your provider to decide if screening is right for you. You and your provider should consider:

    • Your age. The risk of prostate cancer increases after age 50.
    • Your family health history. If members of your family have had prostate cancer, your risk may be higher.
    • Your race. Prostate cancer is more common in African Americans. They also have a higher risk of developing prostate cancer at a younger age and having more serious disease.
    • Your general health. Are you well enough to have treatment for prostate cancer if it’s found?
    • What you prefer. How do you feel about the possible benefits and harms of screening, diagnosis, and treatment?

    NIH: National Cancer Institute

    Getting A Prostate Biopsy

    For some men, getting a prostate biopsy might be the best option, especially if the initial PSA level is high. A biopsy is a procedure in which small samples of the prostate are removed and then looked at under a microscope. This test is the only way to know for sure if a man has prostate cancer. If prostate cancer is found on a biopsy, this test can also help tell how likely it is that the cancer will grow and spread quickly.

    For more details on the prostate biopsy and how it is done, see Tests to Diagnose and Stage Prostate Cancer.

    For more information about the possible results of a prostate biopsy, see the Prostate Pathology section of our website.

    Also Check: Prostate Cancer Treatments Pros And Cons

    Genetic And Genomic Tests For Localized Prostate Cancer

    Genetic testing

    A mans inherited genes predict his prostate cancer risk. For a long time, we have known that there is a family risk in prostate cancer. If your father or brother has prostate cancer, or your mother or sister has breast or ovarian cancer, you are at higher risk of being diagnosed with prostate cancer. To partially quantify that genetic risk, a germline test can be performed before a biopsy. This test of DNA from healthy cells can determine whether you have inherited genetic mutations, such as BRCA1 and BRCA2, known to increase prostate cancer risk. If the test shows youre low risk, you may be able to avoid a biopsy even if you have a slightly elevated PSA, while still being actively monitored for prostate cancer.

    Genomic testing

    If already diagnosed with prostate cancer, you may undergo another type of test for assessing your genetic risk. A genomic test of tissue from your biopsy or prostatectomy can look for somatic mutations, alterations in the DNA of the cancer cells themselves. Genomic tests measure expression of various genes that relate to how aggressive a cancer is likely to be. They indicate how rapidly cancer cells are growing and how genetically abnormal they are relative to normal cells.

    RELATED ARTICLES

    Most Popular